Product
AAVrh.10hFXN
1 clinical trial
4 indications
Indication
Friedreich AtaxiaIndication
CardiomyopathyIndication
Cardiac HypertrophyIndication
Cardiac FibrosisClinical trial
Phase IA Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's AtaxiaStatus: Recruiting, Estimated PCD: 2028-12-31